Effective therapeutics to counteract the formation of amyloid plaques in Alzheimer’s disease and type 2 diabetes are not yet available.
Diabetes, for far too long, has been characterized as a condition that shortens the life expectancy. Earlier, it was a condition that was diagnosed
Get a little dLife delivered to your inbox every week.
Leave this field empty if you’re human: